Advertisements

Йокс-Тева

Quick links to important sections

Йокс-Тева

Advertisements
Advertisements

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Йокс-Тева

Quick Facts Overview

Property Description
Active Ingredients Povidone-iodine, Allantoin
Form Oromucosal Spray, Topical Solution
Pharmacological Class Broad-spectrum Antiseptic, Mucosal Protectant
Common Use Local disinfection and soothing of oral/pharyngeal mucous membranes
Type Combination Product (Synthetic/Derived)

What Type of Medicine is Йокс-Тева? (Classification and Identity)

Йокс-Тева is a pharmaceutical preparation classified as a broad-spectrum antiseptic and mucosal protectant, intended for local application on the mucous membranes of the mouth and throat. It is defined as a combination product due to its two active ingredients.

This medicine is available primarily as an oromucosal spray and a topical solution. The preparation is formulated for a local topical route of administration, concentrating its effects on the affected area. Povidone-iodine, the primary germicidal component, is an iodophor, a class of antimicrobial agents recognized for effective local cleansing.

Composition: Dual-Action Active Ingredients (Povidone-iodine and Allantoin)

Causative efficacy is rooted in the synergistic action of its two active ingredients: Povidone-iodine (PVP-I) and Allantoin. Povidone-iodine provides the powerful, rapid germ-killing action, while Allantoin is included for its protective and soothing properties. This combination is utilized to address irritation.

The inclusion of Allantoin provides a crucial demulcent and epithelial-supporting effect, a feature that differentiates the formula from standard single-component antiseptic mouthwashes. The active substances are carried in an aqueous-ethanolic solution base.

General Purpose: How Does Йокс-Тева Help?

The general purpose of Йокс-Тева is to achieve localized disinfection and surface support in the oral cavity and throat, typically for temporary relief of general throat and mouth discomfort. By combining the strong microbicidal properties of Povidone-iodine with the soothing action of Allantoin, the product is positioned to offer rapid, effective surface cleansing while simultaneously supporting the recovery of irritated mucous membranes.

Advertisements

What side effects are possible with Йокс-Тева?

Possible Side Effects and Safety Information

Official regulatory documentation structures the safety profile of this medicine based on local effects and potential systemic risks associated with iodine absorption.

Adverse Reaction Categories

Adverse reactions are classified according to frequency and the physiological systems affected, based on regulatory standards. The primary documented reactions are generally related to the Immune System and Skin and Subcutaneous Tissue.

Category Description
Rare Reactions Include hypersensitive skin reactions, such as contact dermatitis, pruritus, and erythema.
Very Rare Reactions Iodine-induced hyperthyroidism has been documented in individuals with a pre-existing thyroid predisposition.
Not Known Frequency Systemic effects such as acute renal failure, metabolic acidosis, and anaphylactic reactions are reported, typically following substantial or prolonged absorption that exceeds standard oromucosal use.

Key Safety Constraints

Safety constraints primarily relate to the systemic absorption of iodine. The risk of clinically significant systemic effects on the Endocrine Disorders (thyroid) and Renal Disorders systems is officially linked to prolonged or extensive use of the preparation.

Regulatory labeling specifies that use is contraindicated or requires particular caution in specific patient populations, including individuals with pre-existing thyroid disease (e.g., hyperthyroidism) and women who are pregnant or breast-feeding.

Furthermore, the medicine's constituents may interfere with the results of certain thyroid function tests.

Advertisements

Overdose and Emergency Response

Overdose symptoms for Йокс-Тева are linked to acute systemic absorption of iodine, the primary active component, following ingestion of large quantities or widespread topical misuse. Overdose manifestations documented in regulatory sources include local corrosive effects such as a metallic taste in the mouth, burning or pain in the throat, and severe gastrointestinal symptoms like nausea, vomiting, abdominal pain, and diarrhea. Systemic toxicity may also present with fever, tachycardia, and seizures.

Official regulatory labeling identifies several life-threatening outcomes that require urgent attention, including acute renal failure (anuria), circulatory collapse, and laryngeal or pulmonary edema. Due to the potential for these severe complications, regulators mandate that individuals seek immediate medical attention for any suspected overdose. Specialized hospital treatment is required for management.

Management is strictly symptomatic and supportive, as no specific antidote is known for iodine poisoning. Officially described procedures may include gastric lavage with starch solution or the use of haemodialysis to reduce toxic serum iodine concentrations. Vomiting should not be induced due to the caustic risk. Monitoring of renal and thyroid function is required due to the elevated risk of hyperthyroidism in patients with pre-existing thyroid disease or in the elderly, and hypothyroidism risk in neonates.

Advertisements

Therapeutic Uses of Йокс-Тева

What Йокс-Тева Treats: Main Uses and Benefits

Йокс-Тева is a topical medication that may assist with managing symptoms that interfere with daily functioning in the oropharyngeal area (mouth and throat). The active ingredient, povidone-iodine, is commonly used across domains where additional symptomatic support is needed. This includes the management of conditions characterized by periods of heightened symptoms, such as tonsillitis and pharyngitis (throat infections).

The solution is applied in addressing symptom clusters that may become intense or disruptive, specifically those symptoms related to inflammatory or irritative states. It is relevant for easing the discomfort associated with conditions presenting with systemic or localized discomfort in the throat. It provides supportive relief when symptoms interfere with routine activities, which contributes to easing the overall symptom load and supports patients during episodes of heightened discomfort. This product is commonly used when short-term symptomatic assistance is needed and is relevant in contexts involving heightened systemic burden. It helps improve day-to-day comfort during symptomatic periods. Additionally, it may assist with maintaining functional stability during phases when symptoms become more noticeable.

Quick Fact: Relief for Sore Throat Discomfort

Regulatory References

  1. Government of India CDSCO approval detail
Advertisements

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Йокс-Тева — Official Regulatory Information

The eligibility profile for Йокс-Тева is defined by specific population rules documented in official government regulatory labeling. Use of the medicine is allowed for adults and adolescents aged 6 years and above under standard labeled conditions.

Populations for Whom Use is Contraindicated

Use of the product is strictly contraindicated in several groups due to potential risks, primarily related to iodine absorption and sensitivity:

  • Patients with known hypersensitivity to iodine, povidone, or any excipients.
  • Patients with hyperfunction of the thyroid (hyperthyroidism) or other manifest thyroid diseases like goiter.
  • Patients currently receiving lithium therapy.
  • Children below 6 years of age.

Age-Specific and Conditional Restrictions

Population Group Eligibility Status
Children under 6 Contraindicated
Pregnancy/Lactation Restricted: Use only if strictly indicated and kept to the absolute minimum dose and duration.
Renal Insufficiency Requires special caution, particularly with regular application to the mucosa.
Radioiodine Procedure Prohibited for four weeks before, during, or after administration.

These constraints establish which patient characteristics and clinical states determine who can safely use the medicine, as defined by regulatory authorities.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for this product is defined primarily by the chemical properties of Povidone-iodine and the potential for systemic absorption of iodine, rather than classical metabolic (CYP enzyme) or drug-transporter interactions.

Official Interaction Restrictions

Restriction Type Interacting Substance(s) Official Regulatory Statement
Contraindicated Combination Mercury-Containing Products Co-administration is restricted to prevent the formation of caustic mercury iodide.
Additive Pharmacodynamic Effect Lithium Therapy Concurrent use is cautioned or restricted due to the risk of an additive effect suppressing thyroid function.
Interference with Diagnostics Radioiodine Agents Iodine absorption can officially interfere with the thyroid's uptake of radioiodine, which impacts both diagnostic procedures and planned therapy.
Reduced Efficacy Blood, Pus, or Protein The product's antimicrobial action is significantly impaired by contact with unsaturated organic compounds, such as protein or bodily fluids present in wounds or infections.
Timing Restriction Octenidine-Containing Antiseptics Co-administration or application immediately following octenidine products should be avoided to prevent local, transient dark discolorations.

These official statements specify mandatory separation rules and prohibited combinations documented in regulatory prescribing information for topical iodophor preparations.

Advertisements

Mechanism of Action

How the Agent Disrupts Microorganisms

This mechanism involves the direct, non-specific oxidation of essential proteins and structures within susceptible microorganisms, such as bacteria. The active agent penetrates the microbial cell and initiates chemical reactions that denature critical cellular components. This chemical disruption leads to the functional impairment of these cells, resulting in a decrease in the local microbial population on the surface of the mouth and throat.


Localized Action and Prolonged Effect

The formulation contains binding agents that promote strong adherence to the mucosal lining of the oropharynx. This interaction creates an adhesive layer that functions as a localized reservoir for the active substance. The reservoir facilitates the sustained release of the agent, prolonging the physiological effect by maintaining the agent's action at the site of application and thereby influencing the microbial environment.

Advertisements

Dosage and Administration Information

The usage of Йокс-Тева is based on instructions for its localized topical administration to the mouth and throat. The product is strictly for oromucosal use only and is delivered via a metering spray system.

Administration Scope

The standard adult dose is established as one spray applied directly to the affected region of the oral or pharyngeal mucous membrane. The general dosing regimen allows for administration on an as-needed basis, typically repeated every 3 to 4 hours. Standard guidelines enforce a constraint on total daily use, limiting the frequency to a maximum of up to 3 applications per day.

Procedural Requirements

Administration requires specific procedural steps for accurate delivery. Prior to initial use, the spray pump must be primed by operating it until a uniform mist is produced. During application, the patient must hold their breath and avoid inhaling the spray to prevent the liquid from entering the respiratory tract. The nozzle should be wiped clean and the cap replaced after each use. Due to the aqueous-ethanolic base, the solution is considered flammable.

Age and Duration Constraints

Instructions set clear parameters for use in specific populations and over time. The product is not permitted for use in children under 6 years of age. For individuals aged 6 years and older, the standard adult dosing regimen is applicable. The protocol limits continuous self-treatment to a maximum duration of 7 consecutive days. This framework dictates the application method and adherence to defined time limits.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Йокс-Тева

Evidence for Symptom Management and Local Disinfection in the Oropharynx

The research base for Йокс-Тева was studied for local soothing and disinfection across various study types, primarily focusing on the main active antiseptic ingredient. Studies were evaluated in adults presenting with acute symptoms in the mouth and throat, such as those associated with fluctuating or episodic manifestations like sore throat or pharyngitis. Researchers examined both short-term measurements of relief and the medicine's local action against microbes.

The research included Randomized Controlled Trials (RCTs), some of which was compared to an inactive substance (placebo) or another standard local treatment. These trials were used in research exploring how symptoms change over time, tracking patient-reported outcomes describing perceived discomfort and overall comfort during episodes of acute symptoms. Studies also included systematic reviews, which synthesize data across multiple trials.

Studies Evaluating Clinical Symptoms and Function

In these trials, researchers monitored outcomes related to physical discomfort and outcomes reflecting daily functioning or activity level. Studies were conducted during periods of increased symptom activity, and researchers were studies observing responses over defined time intervals. Findings describe patterns observed in the studies regarding the evolution of symptoms in the observed populations. These findings help contextualize how patients reported their experience during acute, disruptive episodes, but research does not determine whether an individual will respond similarly.

Research on Local Microbial/Viral Load

Research has also explored the local, short-term action of the antiseptic ingredient. These studies focused on measuring viral load changes or the presence of bacteria in the mouth and throat after application. Data show patterns related to the local reduction of these microbial or viral measures. Studies in this area also included laboratory (in-vitro) and animal research, with the findings contributing to the broader evidence landscape regarding how the ingredient was studied for local disinfection.


Evidence Gaps and Areas of Scientific Uncertainty

A notable limitation in the research landscape is that many clinical trials focus on the antiseptic ingredient alone. As a result, the specific role or contribution of the Allantoin component in the Йокс-Тева combination product is not fully established by dedicated studies. Furthermore, findings were mixed across various studies due to differences in the concentration of the antiseptic used and the method of application (spray versus gargle). Evidence is limited in its ability to provide clear insights into long-term outcomes or sustained effectiveness beyond the short-term use for which it was studied for.

Key Studies & References Regulatory Approval Detail: Povidone Iodine Throat Spray (CDSCO, Government of India)

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Йокс-Тева (FAQ)

Q: Does Йокс-Тева only target bacteria, or does it also work against viruses?

Official information confirms that povidone-iodine, the primary active ingredient, is a broad-spectrum antiseptic. This means it is active against a wide range of microorganisms. Studies and official documents indicate its action includes activity against bacteria, fungi, protozoa, and viruses.


Q: Is the spray designed to treat only the symptoms or the underlying cause of infection?

The product is formulated to serve a dual purpose. The antiseptic component works to reduce the local microbial population on the mucous membranes, addressing a potential underlying cause of irritation. Simultaneously, the allantoin component is included to provide soothing and mucosal support for symptom relief.


Q: What is the difference between this product and other widely known iodine-containing throat sprays?

According to the official product information, the formula is distinguished from standard single-component antiseptic products by the inclusion of Allantoin. This ingredient provides an additional protective and soothing effect for the mucous membrane, which is not present in all antiseptic mouth and throat treatments.


Q: Is it normal for the spray to cause a temporary stinging or burning sensation?

Yes, a localized and temporary irritation, such as a burning or stinging sensation in the mouth or throat, has been reported as a common effect upon application. If this sensation is severe, worsens, or does not go away, discontinuation of use and consultation with a healthcare professional are typically recommended.


Q: Is it necessary to rinse the mouth with water before or after using the spray?

The official instructions require the user to hold the medicine briefly in the mouth or throat after application and then spit out the liquid to avoid swallowing. Rinsing with water afterward is not specifically required unless otherwise advised by a healthcare team.


Q: Does the spray need to be diluted before use?

No, the oromucosal spray is a ready-to-use preparation. It is applied directly to the affected area as directed in the product instructions without dilution.


Q: What is the official instruction if irritation or swelling develops after using the spray?

If severe irritation, swelling, or blistering develops after use, official guidance indicates that the product should be stopped immediately, and contact with a healthcare professional is recommended.


Q: What should I do if my symptoms do not get better after using the spray for a few days?

If symptoms do not start to get better or if they worsen after a few days of self-treatment, official guidance indicates that contact with a healthcare professional is recommended. This also applies if the sore throat is accompanied by signs like a high fever or severe headache.


Q: What are the risks if a small amount of the spray is accidentally swallowed?

Instructions advise against swallowing to prevent the risk of iodine absorption. In the event of accidental ingestion, official sources recommend contacting emergency services or a poison control center immediately. Symptoms may include gastrointestinal upset, nausea, vomiting, or diarrhea.


Q: Why do instructions often emphasize not swallowing the liquid?

The primary reason is to prevent the risk of iodine absorption, which can occur if the liquid is ingested instead of being spat out. Systemic absorption of iodine has the potential to lead to thyroid disturbances, gastrointestinal upset, or other systemic effects in rare cases.


Q: What are the signs of a serious allergic reaction to povidone-iodine?

Although rare, signs of a serious allergic reaction may include difficulty breathing or swallowing, rash, hives, or swelling of the face, lips, tongue, or throat. If these symptoms occur, official warnings state that emergency medical help should be sought immediately.


Q: Will Йокс-Тева permanently stain my teeth or clothing?

According to patient information, the spray is not expected to permanently stain teeth. The characteristic brown color is due to the active ingredient, povidone-iodine. While the solution may temporarily stain clothing or fabric, stains can typically be removed with washing and the aid of a stain remover.


Q: Is it true that the brown color of the spray is due to iodine?

Yes, the characteristic brown color of the solution is directly caused by the presence of the active ingredient, povidone-iodine.


Q: Is there information about using Йокс-Тева for patients with certain dental work or dentures?

Official guidance indicates that removable dentures or braces are typically removed from the mouth prior to using the spray. This is because these devices can sometimes become temporarily discolored by the solution.


Q: Does Йокс-Тева interact with other mouthwashes containing ingredients like chlorhexidine?

Official warnings state that concurrent use of different local antiseptic products is generally avoided unless specifically directed by a healthcare professional. This is because the compatibility and combined effect of using two different active antiseptics at the same time may not be fully established.


Q: Are there any common over-the-counter (OTC) medicines or supplements that interact with the spray?

Official drug information generally recommends consultation with a healthcare professional regarding all prescription medicines, over-the-counter (OTC) drugs, and herbal supplements to check for potential interactions.

Advertisements

How should Йокс-Тева be stored and disposed of?

How to Store and Dispose of Jóks-Teva (Jox)

Official regulations require specific conditions for storing and disposing of Jóks-Teva oromucosal spray/solution to maintain its stability and ensure safety.


Required Storage Conditions

The medicine must be stored at a temperature below 25°C and must not be exposed to freezing or direct heat. To protect the light-sensitive solution, Jóks-Teva must be kept in its original container and the cap must remain tightly closed when not in use. Always store the product out of the sight and reach of children.

Official Disposal Instructions

Jóks-Teva must not be disposed of via wastewater or with household waste. Unused or expired product should be returned to a pharmacist or a designated local pharmaceutical waste handler for disposal, following official local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Йокс-Тева found in:

A-Z Index: